Zelig Eshhar, PhDInventor of CAR-T Initiated collaboration with Cell Source to develop allogenic CAR-T + Veto cell therapiesWeizmann Institute of Science (Israel) Developer of core technology used by KITE Pharma…
read moreElizabeth Shpall, MDHead of Cell Manufacturing, Phase I II Clinical Trials Director, Cell Therapy LaboratoryMD Anderson Cancer Center Director of the Cord Blood Bank Professor and Deputy Chair, Department of…
read moreRichard Champlin, MDPrincipal Investigator,Phase I II Clinical Trials Chair, Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer MedicineMD Anderson Cancer Center Past Chair, Center for International Blood…
read moreProfessor Yair Reisner, Ph.DChairman, Scientific Advisory Board Director, Stem Cell Research, Department of Stem Cell Transplantation, MD Anderson Cancer Center, Houston, Texas Professor Reisner's complete background is located elsewhere in…
read moreDr. Robert NegrinScientific Advisory Board Member Director of the Bone and Marrow Transplantation Division and Professor of Medicine at Stanford University A Harvard trained MD, Dr. Negrin studied Internal Medicine…
read moreDr. Steven BurakoffScientific Advisory Board Member Dean of Cancer Innovation and Chief of Pediatric Oncology at the Icahn School of Medicine Dr. Burakoff is the former Director of the Tisch…
read moreDr. Herman WaldmannScientific Advisory Board Member Former Department Head and Professor Emeritus of Pathology at the Oxford Medical School and Clinical Director of Oxford’s Therapeutic Antibody Centre Dr. Waldmann gained…
read moreDr. Hermann EinseleScientific Advisory Board Member Professor of Internal Medicine and Director of the Department of Internal Medicine of the Julius Maximilian University, Würzburg, Germany. Dr. Einsele trained in Germany…
read more